Generic Specialties

What Generic Specialties does

Generic Specialties, Inc. is a privately held, vertically integrated generic pharmaceutical manufacturer founded in 1999 and headquartered in Orlando, Florida. The company manufactures, licenses, develops, markets, and distributes generic pharmaceutical products primarily to the U.S. prescription drug market, with exports to Central and South American markets. It serves large enterprise buyers including the nation's largest wholesalers, distributors, warehousing and non-warehousing chain drugstores, and managed care providers, operating a sales-led GTM motion with dedicated regional sales managers for export markets. The product portfolio spans pharmaceutical formulations (analgesics, anti-infectives, cardiovascular, gastrointestinal, oncology, critical care, anesthetic, hormones, and others), large and small volume parenterals, total parenteral nutrition, disposable medical devices (under the Oneuse brand), neutraceuticals, and FDA/Health Canada approved hand sanitizers and wipes. The company also supplies over 200 Active Pharmaceutical Ingredients (APIs) through partnership arrangements.

The company operates four manufacturing sites — three in the United States (FL, an Ex-Pfizer site in NY, and an Ex-Enzon site in NJ operated in conjunction with Axcellerate Pharma) and a manufacturing facility in Vadodara, India — supported by DSIR-approved R&D facilities in Ahmedabad, India. This dual-shore production footprint is positioned as a cost-advantage structure, providing flexibility to develop and manufacture products at either US or India facilities while maintaining cGMP and US-FDA quality standards. The company holds a specialized position as the only known manufacturer of certain hormone APIs, including Esterified Estrogen and Methyl Testosterone tablets. Founder Ashwin Mehta leads the company as Director, and the firm is described on its own materials as a "rapidly growing" organization with an M&A-oriented growth approach centered on acquiring valued assets and facilities. The company also maintains sub-brands including Oneuse (disposable medical devices), Eponir (erythropoietin injection), and Glutarnir (oral glutamine supplement).

Revenue mechanics are typical of mid-market generic pharmaceutical distribution: B2B sales of finished dosage products, APIs, devices, and consumer sanitizers at contract-negotiated prices to enterprise channel buyers, with no public pricing or revenue disclosure. The company is privately held with no disclosed institutional funding, no public listing, and no revenue figures available in the source data, and no public customer logos or segment revenue splits are provided.

Name

Generic Specialties

Legal name

Generic Specialties, Inc.

Website

https://genericspecialties.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Generic Specialties, Inc. is a privately held, vertically integrated generic pharmaceutical manufacturer headquartered in Orlando, Florida, founded in 1999, that produces finished generic drugs, 200+ APIs, medical devices, and sanitizers across US and India facilities for the US prescription drug market and Central/South American export markets.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

akta.pro secondary industries

Generic APIs & Intermediates (Active Ingredients) (HLAIABAG), Sterile Injectable Generics (HLAIABAC), Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Generic pharmaceuticals
• Active pharmaceutical ingredients
• Sterile injectables
• Pharmaceutical contract manufacturing
• Disposable medical devices

Headquarters

HQ city

Orlando

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Generic Pharmaceutical Products: Manufacture, acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the U.S. prescription drug market with exports to Central and South American markets.
2. API Supply: Supply of Active Pharmaceutical Ingredients (APIs) through partnership arrangements, with commercialized supply lines for over 200 APIs.
3. Sanitizers and Wipes: Manufacturing and marketing of hand sanitizing products and wipes in various sizes, US-FDA and Health Canada approved.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Generic Specialties, Inc. is a vertically integrated manufacturer engaged in the manufacture, acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the U.S. prescription drug market. The company markets a broad portfolio of generic formulations, sterile injectables, oncology and critical care medicines, APIs, disposable medical devices, and sanitizers across multiple pack sizes to wholesalers, distributors, chain drugstores, and managed care providers. It operates cGMP-compliant U.S.-FDA approved facilities in the U.S. and India and exports to Central and South American markets.

Product overview

Generic Specialties is a generic pharmaceutical company offering a broad portfolio of generic medications and healthcare products. The company operates as a vertically integrated manufacturer with FDA-approved facilities in the USA and India. Their product portfolio includes: (1) Pharmaceutical Formulations covering multiple therapeutic areas including analgesics, anti-inflammatory, anti-infectives, cardiovascular, and gastrointestinal medications; (2) Critical Care Medicines including specialty anti-infective kits and carbapenem antibiotics; (3) Oncology Products for various cancers; (4) Large and Small Volume Parenterals (IV solutions); (5) Total Parenteral Nutrition products; (6) Disposable Medical Devices including syringes, needles, and gloves; (7) Pharmaceutical APIs (200+ products); (8) Minerals and Vitamin APIs; (9) Neutraceuticals and nutritional supplements; (10) Anesthetic range products; and (11) Consumer products like hand sanitizers and wipes. The company distributes through US wholesalers, distributors, chain drugstores, and managed care providers, and exports to Central and South American markets.

Differentiator

Problem solved

Functional benefit

Brands

• Oneuse: Disposable medical devices brand including syringes, needles, infusion sets, gloves, and swabs
• Generic Specialties PHARMA INDIA
• Eponir
• Glutarnir

Products and services

• Pharmaceutical Formulations Generic pharmaceutical formulations spanning analgesics, anti-inflammatory, anti-infectives, cardiovascular, gastrointestinal, antihistamines, antiasthmatics, antimalarials, hormones, gynecological, CNS, ophthalmic, and other therapeutic categories, offered in tablets, capsules, injectables, ointments, liquids, and pediatric drops for U.S. prescription drug distribution.
• Critical Care Medicines Specialty hospital products including specialty anti-infective kits, carbapenem antibiotics, and injectable medications for critical care settings, sold to pharmaceutical distributors and hospitals.
• Oncology Products Generic oncology medications including tablets, capsules, and injections indicated for various cancers including breast cancer, leukemia, lung cancer, and immunosuppressant therapy.
• Large Volume Parenterals Large volume sterile IV solutions including dextrose (5%-50%), electrolytes, diuretics, and dialysis solutions for hospital and clinical use.
• Small Volume Parenterals Small volume sterile injectable products including anti-infectives, diluents, ophthalmic preparations, respules, and other sterile injectable formulations.
• Total Parenteral Nutrition Complete parenteral nutrition products including amino acid solutions, fat emulsions, and mixed TPN formulations in glass bottles and bags with varying caloric content for clinical nutrition.
• Disposable Medical Devices Single-use medical devices including syringes, needles, infusion sets, blood transfer sets, insulin syringes, surgical and examination gloves, and adhesive bandages, marketed under the Oneuse brand.
• Pharmaceutical APIs Active pharmaceutical ingredients including cardiovascular drugs (amlodipine, atorvastatin), antibiotics (ciprofloxacin), pain management APIs (paracetamol, tramadol), specialty APIs (imatinib, ergotamine), and hormone APIs (Esterified Estrogen, Methyl Testosterone), with over 200 commercialized APIs supplied through partnership arrangements.
• Minerals and Vitamin APIs Mineral and vitamin active pharmaceutical ingredients including cyanocobalamin, folic acid, mecobalamin, vitamin C, D, E, K, thiamine, riboflavin, and B-complex vitamins, supplied to other pharmaceutical manufacturers.
• Hand Sanitizing and Moisturizing Gels and Wipes Hand sanitizing gels in sizes from 50ml to 5L plus sanitizing wipes, US-FDA and Health Canada approved, for institutional and consumer distribution.
• Surface Disinfecting Wipes Surface disinfecting wipes and electronic device disinfecting wipes for sanitation of surfaces and electronics, US-FDA and Health Canada approved.
• Neutraceuticals and Nutritional Supplements Nutritional supplements including vitamins, minerals, multivitamins, protein supplements, hematinic syrups, and bodybuilding products in tablets, capsules, liquids, powders, pediatric drops, and injectables, including the Glutarnir oral glutamine supplement (Eponir erythropoietin injection).

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered minor and core.

• Axcellerate PharmaminorOthersNJ, USA manufacturing facility referenced as Ex-Enzon, with link to http://www.axcelleratepharma.com indicating some operational relationship or facility acquisition history.
• Various High Quality API SupplierscoreTechnology or IntegrationThrough partnership arrangements, Generic Specialties supplies numerous high quality APIs with commercialized supply lines for over 200 APIs. Total Quality Management is emphasized with cGMP compliance, validation, stability studies, documentation, safety, health and environmental standards.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Apotex Inc. One of the largest Canadian generic pharmaceutical manufacturers with vertically integrated API and finished-dose production across many of the same therapeutic categories (analgesics, antibiotics, cardiovascular) Generic Specialties serves. Directly comparable as a privately held, multi-site generic manufacturer targeting the U.S. prescription market.
• Lupin Pharmaceuticals: India-headquartered global generic manufacturer with FDA-approved U.S. manufacturing and a broad small-molecule generic portfolio overlapping Generic Specialties' formulations. Comparable as a vertically integrated US-India generic player targeting the same wholesalers and chain drugstores.
• Aurobindo Pharma: Indian generic manufacturer with one of the largest U.S. ANDA portfolios, vertically integrated API-to-finished-product operations, and an established U.S. distribution footprint. Closely comparable to Generic Specialties in business model, cost structure, and customer base.
• Amneal Pharmaceuticals: U.S.-headquartered generic and specialty pharmaceutical manufacturer with vertically integrated manufacturing, broad small-molecule portfolio, and distribution through the same major U.S. wholesalers. Highly comparable as a private-then-public generic peer with similar product breadth and customer channels.
• Lannett Company: U.S. generic pharmaceutical manufacturer with a portfolio spanning oral solids, liquids, injectables, and APIs, distributing through the same large wholesaler and chain drugstore channels. Comparable as a smaller-scale, multi-therapeutic U.S. generic competitor with similar go-to-market motion.
• Glenmark Pharmaceuticals: India-based global generics manufacturer with U.S. FDA-approved facilities and a broad generic formulations portfolio overlapping Generic Specialties' therapeutic mix (cardio, anti-infectives, CNS, hormones). Directly comparable on vertical integration and U.S. channel strategy.
• Zydus Pharmaceuticals (Zydus Cadila): India-origin vertically integrated generic manufacturer with large U.S. presence, broad small-molecule and specialty injectable portfolio, and similar distribution through top wholesalers. Comparable across business model, geography, and customer profile.

Broad incumbents

• Teva Pharmaceutical Industries: World's largest generic drug manufacturer with an extensive U.S. portfolio across virtually all of Generic Specialties' therapeutic categories. While much larger, Teva is a directly relevant incumbent that defines the competitive price benchmark Generic Specialties must meet in U.S. wholesaler contracts.
• Viatris (formerly Mylan): Global generics and biosimilars powerhouse with broad U.S. small-molecule generic coverage including injectables and hormones. Serves the same large wholesalers and chain drugstores; directly relevant as the dominant scale competitor shaping generic pricing dynamics.
• Sandoz (Novartis): Global generic and biosimilar division of Novartis with a broad U.S. small-molecule portfolio including sterile injectables and APIs. Comparable as a large, vertically integrated incumbent that competes in many of the same ANDA categories and wholesale relationships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/GenericSplties
• Facebookfacebook.com/Generic.Specialties
• LinkedInlinkedin.com/company/generic-specialties-inc-?trk=tyah&trkInfo=tarId%3A1418684776396%2Ctas%3Ageneric+spec%2Cidx%3A1-2-2

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Generic Specialties